Viewing Study NCT04102150


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-27 @ 1:20 PM
Study NCT ID: NCT04102150
Status: COMPLETED
Last Update Posted: 2025-02-10
First Post: 2019-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma
Sponsor: Daiichi Sankyo Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module